[Indications for use of calcium antagonists].
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D002118:Calcium / Q000037:antagonists & inhibitors*; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D003327:Coronary Disease / Q000188:drug therapy*; D005260:Female; D005275:Fendiline / Q000627:therapeutic use; D006801:Humans; D006946:Hyperinsulinism / Q000188:drug therapy; D006973:Hypertension / Q000188:drug therapy*; D009543:Nifedipine / Q000627:therapeutic use; D007752:Obstetric Labor, Premature / Q000188:drug therapy; D010235:Paraganglioma / Q000188:drug therapy; D010480:Perhexiline / Q000627:therapeutic use; D011247:Pregnancy; D011299:Prenylamine / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use; D014700:Verapamil / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D002316:Cardiotonic Agents; D014665:Vasodilator Agents; D014700:Verapamil; D009543:Nifedipine; D011299:Prenylamine; D010480:Perhexiline; D005275:Fendiline; D002118:Calcium
Indikationen der Calcium-Antagonisten.